Cost conundrum: the investment in clinical trials remains the same but approved drugs will have a smaller market. So how is Personalised Medicine to be financed?
After 7 years of deliberation, the European Commission is to authorise the Amflora genetically modified potato to be cultivated for industrial purposes.
Imperial College London is to make its expertise in innovation management, technology transfer and engineering available to the Innovation Outreach Programme.
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.